Tuya Pal, MD, FACMG

Dr. Pal’s research is focused on identification of basic or clinical research: genetic risk factors that place individuals at a higher risk for cancer, as well as strategies to reduce this risk, including efforts focused in underserved populations. Her research spans both the cancer prevention and control continuum as well as the care delivery continuum. Since 2005, she has led multiple studies to investigate the etiology of early onset breast cancer in black women. Since creating the Inherited Cancer Registry (ICARE) Initiative in 2010, she has led multiple efforts to better understand the provision of clinical cancer genetic services across diverse populations, healthcare settings, and providers, at both the patient and provider level.

For more information on Dr. Pal, click here.